Population size estimation for quality control of ChIP-Seq datasets

PLoS One. 2019 Aug 29;14(8):e0221760. doi: 10.1371/journal.pone.0221760. eCollection 2019.

Abstract

Chromatin immunoprecipitation followed by sequencing, i.e. ChIP-Seq, is a widely used experimental technology for the identification of functional protein-DNA interactions. Nowadays, such databases as ENCODE, GTRD, ChIP-Atlas and ReMap systematically collect and annotate a large number of ChIP-Seq datasets. Comprehensive control of dataset quality is currently indispensable to select the most reliable data for further analysis. In addition to existing quality control metrics, we have developed two novel metrics that allow to control false positives and false negatives in ChIP-Seq datasets. For this purpose, we have adapted well-known population size estimate for determination of unknown number of genuine transcription factor binding regions. Determination of the proposed metrics was based on overlapping distinct binding sites derived from processing one ChIP-Seq experiment by different peak callers. Moreover, the metrics also can be useful for assessing quality of datasets obtained from processing distinct ChIP-Seq experiments by a given peak caller. We also have shown that these metrics appear to be useful not only for dataset selection but also for comparison of peak callers and identification of site motifs based on ChIP-Seq datasets. The developed algorithm for determination of the false positive control metric and false negative control metric for ChIP-Seq datasets was implemented as a plugin for a BioUML platform: https://ict.biouml.org/bioumlweb/chipseq_analysis.html.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Area Under Curve
  • Binding Sites
  • Chromatin Immunoprecipitation Sequencing*
  • Databases, Nucleic Acid*
  • Quality Control
  • ROC Curve
  • Sequence Analysis, DNA*
  • Transcription Factors / metabolism

Substances

  • Transcription Factors

Grants and funding

This work is supported by the Russian Science Foundation, grant agreement № 19-14-00295 (http://rscf.ru/en/) to SKK, YVK, ISY, RNS, ASR, FAK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.